Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.
about
State of the art: stem cells in equine regenerative medicineAllogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodiesEffect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro.Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Other Phenotypic Cell Surface Markers.Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitroPhenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.Biopsy Needle Advancement during Bone Marrow Aspiration Increases Mesenchymal Stem Cell ConcentrationRepeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine modelTenogenesis of bone marrow-, adipose-, and tendon-derived stem cells in a dynamic bioreactor.Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord.Mesenchymal Stromal Cells from Osteoarthritic Synovium Are a Distinct Population Compared to Their Bone-Marrow Counterparts regarding Surface Marker Distribution and Immunomodulation of Allogeneic CD4+ T-Cell Cultures.Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.Cryopreservation of equine mesenchymal stem cells in 95% autologous serum and 5% DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95% and DMSO at 10 or 5.Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model.Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells.Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?Isolation of equine peripheral blood stem cells from a Japanese native horse.Immunophenotypic characterization of ovine mesenchymal stem cells.Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.
P2860
Q27005709-21EEED10-116D-40F2-9510-953EF65EB2B3Q33658311-9EF2AA8A-1FB2-4B88-907D-A328549525E0Q33730401-CF2F700D-C8ED-4A6B-BD15-858C3271875BQ33785781-7296B228-B327-4D76-8C87-6598B75CE64AQ35155712-0A816A7C-286F-4B1B-B01D-990FE800BBD1Q35527042-AF1B32BD-7F05-4F15-A6BB-01EED29FCC7BQ35551421-36D30E7F-A671-46F5-BE08-F5290025ADD0Q35974485-5B4D6FF3-9705-440F-A11D-B9179F24EE1AQ36681366-B98DF9BF-3475-4478-BE03-41DCF8A530AAQ37671213-22AD7190-36AF-4E14-B674-26D0B76D7AEFQ38734819-7F4C8CDF-C72B-4352-8925-2C4D4FA5276FQ38826755-5E211F5E-CD5E-4C3C-A0C5-5E8D0C0AD21CQ38831977-C1F04066-260C-4468-87F4-39E6E640D61DQ39150444-586FF6F0-F33D-4A9F-8202-403E104B21ACQ40333872-5E4DBFC5-1D90-40A1-A756-752D8099051DQ41048051-ACD3FACC-C479-46D7-9280-DE9B98069CDBQ41866671-3938D0FF-C3EB-47A3-A7BF-5513CA7D1601Q47126440-9C5E2689-7AB0-42FA-A265-4CF0B7002154Q47147635-49250066-C928-40EF-99E4-00BDD1FBEAD1Q47162218-5F6BF9D5-E855-443A-BF1E-EA4EC71E287AQ48827577-5B82A548-4BC0-47C4-9658-A8D3740077CBQ55004213-D2BC09F9-66F0-4FF0-9B01-26E30231DABBQ55344331-F2782A66-47E7-4E8E-81F9-421E32058BD0Q55400692-A4089C58-2767-4648-A706-86C0B6EED194
P2860
Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Equine bone marrow-derived mes ...... g an immune response in vitro.
@ast
Equine bone marrow-derived mes ...... g an immune response in vitro.
@en
type
label
Equine bone marrow-derived mes ...... g an immune response in vitro.
@ast
Equine bone marrow-derived mes ...... g an immune response in vitro.
@en
prefLabel
Equine bone marrow-derived mes ...... g an immune response in vitro.
@ast
Equine bone marrow-derived mes ...... g an immune response in vitro.
@en
P2093
P2860
P356
P1476
Equine bone marrow-derived mes ...... ng an immune response in vitro
@en
P2093
Lauren V Schnabel
Lisa A Fortier
Lynn M Pezzanite
M Julia Bevilaqua Felippe
P2860
P2888
P356
10.1186/SCRT402
P50
P577
2014-01-24T00:00:00Z
P5875
P6179
1024431950